Accès ouvert · CC BY

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Article scientifique 2025 Sciences de la santé Anglais

Résumé

The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed a therapeutic guideline well suited to conditions on the ground. These guidelines answer three essential questions: which patients should be prioritized for treatment with hydroxyurea, which dose should be used, and what follow-up should be implemented in those low-resources countries? The guidelines are given as in a concise document for easy use by practitioners on the ground, available in English and in French.

Citer ce document

Arlet, J.-B., Bernaudin, F., Dème-Ly, I., Coulibaly, B., Corbasson, A., Diagne, I., Diallo, D. A., Diop, S., Eposse, C., Galactéros, F., Hermine, O., Kafando, É., Lainé, A., Montalembert, M. D., Vodouhé, C., Vovor, A., Ranque, B., & Tshilolo, L. (2025). Use of hydroxyurea in French-speaking Sub-Saharan Africa. Annals of Hematology. https://doi.org/10.1007/s00277-024-06180-2

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 17

Téléchargements (hors robots) : 0

Méthode de comptage